StockData
Fulcrum Therapeutics, Inc. logo

Fulcrum Therapeutics, Inc. (FULC) shareholders

FULCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/30
$3.75+0.04 (+1.08%)

Close on Nov 17, 2026Market cap $286.12MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
86M of 76M shares
Institutional holders
155
29 new, 42 sold out
Net institutional buying
14M
In Q2 2026
Insider trades, 12 months
6 buys · 9 sales
Net sold $57.67M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Tang Capital Management, LLC
Joint filing with Kevin Tang (10.40%)
6,913,32910.40%13G (passive) amendmentJul 13, 2026
BlackRock Portfolio Management LLC6,155,4378.10%13G (passive) amendmentSep 30, 2026
RA Capital Management, L.P.
Joint filing with Peter Kolchinsky (11.20%), Rajeev Shah (11.20%) and 1 more
6,053,96011.20%13G (passive) amendmentDec 8, 2025
Oleg Nodelman
Joint filing with EcoR1 Capital, LLC (9.00%), EcoR1 Capital Fund Qualified, L.P. (8.40%)
6,000,0009.00%13G (passive)Jun 17, 2026
Nantahala Capital Management, LLC
Joint filing with Wilmot B. Harkey (8.22%), Daniel Mack (8.22%)
5,475,0408.22%13G (passive)Jun 30, 2026
Kevin Tang
Joint filing with Tang Capital Management, LLC (8.20%)
5,451,8008.20%13G (passive)Jun 3, 2026
Suvretta Capital Management, LLC
Joint filing with Aaron Cowen (9.40%), Averill Master Fund, Ltd. (8.60%)
5,067,3949.40%13G (passive) amendmentMar 31, 2025
BlackRock, Inc.4,802,8807.20%13G (passive) amendmentJun 30, 2026
Adage Capital Management, L.P.
Joint filing with Robert Atchinson (8.50%), Phillip Gross (8.50%)
4,589,0008.50%13G (passive) amendmentJun 30, 2025
Montanova Capital, LLC
Joint filing with Aaron Cowen (5.50%)
3,680,9215.50%13G (passive) amendmentJun 30, 2026
Robert Atchinson
Joint filing with Adage Capital Management, L.P. (5.56%), Phillip Gross (5.56%)
3,000,0005.56%13G (passive)Dec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of FULCValueChange% of portfolio
Nantahala Capital Management, LLC10,950,08014.35%$40.08M+7,900,0400.67%
BlackRock, Inc.8,824,25911.57%$32.30M+3,433,6660.00%
EcoR1 Capital, LLC6,549,8668.58%$23.97MNew1.17%
Tang Capital Management LLC6,521,4128.55%$23.87MNew1.08%
Suvretta Capital Management, LLC3,680,9214.82%$13.47M−2,880,1900.25%
D. E. Shaw & Co., Inc.3,044,3853.99%$11.14M+1,421,1040.01%
Citadel Advisors LLC2,704,5053.54%$9.90M+1,412,0190.00%
Vanguard Capital Management LLC2,697,2163.54%$9.87M+4,2680.00%
Jane Street Group, LLC2,217,4982.91%$8.12M+1,907,0810.00%
State Street Corp2,037,0252.67%$7.46M+487,1740.00%
Adage Capital Partners Gp, L.L.C.2,000,0002.62%$7.32M+1,600,0000.01%
GSK plc1,785,7142.34%$6.54M–1.09%
Qube Research & Technologies Ltd1,748,4672.29%$6.40M+773,7280.01%
Assenagon Asset Management S.A.1,670,4082.19%$6.11M+476,5350.00%
Renaissance Technologies LLC1,647,8002.16%$6.03M+1,634,2000.01%
ADAR1 Capital Management, LLC1,565,0292.05%$5.73M+1,434,4690.26%
Millennium Management LLC1,485,8031.95%$5.44M+1,129,3320.00%
Geode Capital Management, LLC1,432,1331.88%$5.24M−54,4090.00%
Marshall Wace, Llp1,358,4231.78%$4.97MNew0.00%
UBS Group AG1,253,9091.64%$4.59M+938,7240.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202615586M100.0%29 / 7334 / 4247M33M
Q1 202616972M94.0%37 / 7339 / 3817M10M
Q4 202517268M88.6%59 / 4449 / 1623M10M
Q3 202512954M70.5%26 / 4142 / 187M7M
Q2 202512254M71.3%24 / 3446 / 197M4M
Q1 202511751M67.3%18 / 3242 / 194M5M
Q4 202411952M68.1%24 / 3340 / 338M11M
Q3 202413055M72.2%44 / 3135 / 3424M29M
Q2 202412165M85.0%31 / 4526 / 3612M10M
Q1 202412663M82.4%36 / 3428 / 118M8M
Q4 202310162M81.7%31 / 2421 / 1111M6M
Q3 20238157M74.2%15 / 1726 / 217M5M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

154 funds held FULC in Q2 2026, 65% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of FULCValue% of fundAs of
Vanguard Total Stock Market Index Fund2,074,3322.72%$7.59M0.00%Jun 30, 2026
iShares Russell 2000 ETF1,552,7122.04%$5.68M0.01%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF807,5871.06%$2.96M0.69%Jun 30, 2026
Fidelity Small Cap Index Fund646,3790.85%$2.31M0.01%Jul 31, 2026
iShares Russell 2000 Value ETF567,8240.74%$2.08M0.01%Jun 30, 2026
Vanguard Extended Market Index Fund553,3750.73%$2.03M0.00%Jun 30, 2026
BlackRock Advantage Small Cap Core Fund416,7700.55%$2.88M0.05%May 29, 2026
iShares Biotechnology ETF398,0720.52%$1.46M0.02%Jun 30, 2026
Vanguard Russell 2000 Index Fund306,5850.40%$2.12M0.01%May 31, 2026
Fidelity Extended Market Index Fund251,8830.33%$1.74M0.00%May 31, 2026
Schwab U.S. Small-Cap ETF228,4990.30%$1.58M0.01%May 31, 2026
iShares Micro-Cap ETF199,4580.26%$730.02K0.05%Jun 30, 2026
U.S. Micro Cap Portfolio168,6040.22%$603.60K0.01%Jul 31, 2026
Vanguard Strategic Small-Cap Equity Fund162,1210.21%$593.36K0.02%Jun 30, 2026
U.S. Small Cap Portfolio157,0990.21%$562.41K0.00%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Alex SapirSee Remarks, Director193,3600.25%Feb 4, 2026
Alan A. MussoChief Financial Officer0–Feb 4, 2026
Greg TourangeauPrincipal Accounting Officer14,0620.02%Feb 4, 2026
Curtis Gale OltmansChief Legal Officer10,2520.01%Feb 4, 2026
Alan EzekowitzDirector10,9270.01%Jul 2, 2026
James A. GeraghtyDirector90,7140.12%Jul 2, 2026
Katina DortonDirector0–Jul 2, 2026
Robert J. GouldDirector454,8640.60%Jul 2, 2026
Kate HavilandDirector––Jul 2, 2026
Colin HillDirector0–Jul 2, 2026
Sonja BanksDirector0–Jul 2, 2026
Rachel K. KingDirector––Jul 2, 2026
Joshua Lehrer-GraiwerDirector0–May 1, 2026
Kevin Tang10% owner7,080,9459.28%Jul 20, 2026
Capital Management Llc Tang10% owner6,913,3299.06%Jul 20, 2026
Peter Kolchinsky10% owner9,505,92512.46%Dec 10, 2025
Rajeev M. Shah10% owner3,109,7044.08%Dec 10, 2025
Capital Healthcare Fund LP RA10% owner6,145,6828.05%Dec 10, 2025
Ra Capital Management, L.P.10% owner10,229,09913.41%Dec 10, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Kevin Tang
10% owner
Jul 17, 2026Buy+50,945$3.52$179.33K7,080,945
Kevin Tang
10% owner
Jul 16, 2026Buy+116,671$3.56$415.35K7,030,000
Capital Management Llc Tang
10% owner
Jul 15, 2026Buy+107,377$3.56$382.26K6,913,329
Capital Management Llc Tang
10% owner
Jul 14, 2026Buy+53,651$3.56$191.00K6,730,000
Capital Management Llc Tang
10% owner
Jul 14, 2026Buy+75,952$3.58$271.91K6,805,952
Capital Management Llc Tang
10% owner
Jul 13, 2026Buy+12,966$3.54$45.90K6,676,349
Alan Ezekowitz
Director
Jun 26, 2026Sale(10b5-1 plan)−18,000$3.65$65.70K10,927
Robert J. Gould
Director
Feb 2, 2026Sale(10b5-1 plan)−15,000$10.72$160.80K454,864
Robert J. Gould
Director
Jan 2, 2026Sale(10b5-1 plan)−15,000$10.87$163.05K469,864
Robert J. Gould
Director
Jan 2, 2026Sale(10b5-1 plan)−15,000$11.87$178.05K469,864
Curtis Gale Oltmans
Chief Legal Officer
Dec 15, 2025Sale(10b5-1 plan)−3,452$12.92$44.60K10,252
Capital Healthcare Fund LP RA
10% owner
Dec 8, 2025Sale−2,706,397$14.28$38.65M6,145,682
Capital Healthcare Fund LP RA
10% owner
Dec 8, 2025Sale−91,722$14.98$1.37M6,053,960
Capital Healthcare Fund LP RA
10% owner
Dec 8, 2025Sale−1,377,020$13.33$18.36M8,852,079
Robert J. Gould
Director
Nov 19, 2025Sale(10b5-1 plan)−15,000$11.03$165.45K484,864
Greg Tourangeau
Principal Accounting Officer
May 8, 2025Sale−498$5.06$2.52K14,062
Rajeev M. Shah
10% owner
Aug 21, 2024Other−8,500,000––3,109,704
Alex Sapir
See Remarks, Director
Jul 3, 2024Option exercise+150,000$3.27$490.50K193,360
Greg Tourangeau
Principal Accounting Officer
May 7, 2024Sale−236$7.76$1.83K11,571
Greg Tourangeau
Vice President, Finance
Mar 8, 2024Sale−4,884$11.72$57.24K11,807
Alex Sapir
See Remarks, Director
Mar 4, 2024Buy+43,360$11.35$492.14K43,360
Greg Tourangeau
Principal Accounting Officer
May 10, 2023Sale−210$3.31$69515,992
Ra Capital Management, L.P.
10% owner
Jan 20, 2023Buy+1,923,076$13.00$25.00M11,609,704
Robert J. Gould
Interim President & CEO, Director
Jan 13, 2023Sale(10b5-1 plan)−6,766$15.00$101.49K499,864
Capital Healthcare Fund LP RA
10% owner
Jan 4, 2023Buy+122,334$7.03$860.01K9,628,259
Capital Healthcare Fund LP RA
10% owner
Jan 4, 2023Buy+58,369$7.80$455.28K9,686,628
Peter Kolchinsky
10% owner
Dec 27, 2022Buy+4,089$5.99$24.49K9,505,925
Peter Kolchinsky
10% owner
Dec 19, 2022Buy+98,787$5.90$582.84K9,501,836
Ra Capital Management, L.P.
10% owner
Dec 16, 2022Buy+1,341,420$5.42$7.27M9,403,049
Ra Capital Management, L.P.
10% owner
Dec 15, 2022Buy+237,029$5.50$1.30M8,061,629
Ra Capital Management, L.P.
10% owner
Dec 14, 2022Buy+824,600$5.46$4.50M7,824,600
Trv Gp Iii, Llc
10% owner
Dec 13, 2022Other−2,000,000––1,962,202
Robert J. Gould
Director
Jun 7, 2022Option exercise+71,435$7.84$560.05K578,065
Robert J. Gould
Director
Jun 7, 2022Sale(10b5-1 plan)−71,435$8.09$577.91K506,630
Robert J. Gould
Director
Jun 6, 2022Option exercise+24,382$7.84$191.15K531,012
Robert J. Gould
Director
Jun 6, 2022Sale(10b5-1 plan)−24,382$8.10$197.49K506,630
Robert J. Gould
Director
Jun 3, 2022Option exercise+25,551$7.84$200.32K532,181
Robert J. Gould
Director
Jun 3, 2022Sale(10b5-1 plan)−25,551$7.95$203.13K506,630
Robert J. Gould
Director
Jun 2, 2022Option exercise+16,689$7.84$130.84K523,319
Robert J. Gould
Director
Jun 2, 2022Sale(10b5-1 plan)−16,689$7.92$132.18K506,630
Greg Tourangeau
Controller
May 6, 2022Award+3,250––16,202
Robert J. Gould
Director
Apr 7, 2022Option exercise+5,631$7.84$44.15K512,261
Robert J. Gould
Director
Apr 7, 2022Sale(10b5-1 plan)−5,631$24.02$135.26K506,630
Robert J. Gould
Director
Apr 5, 2022Option exercise+52,552$7.84$412.01K559,182
Robert J. Gould
Director
Apr 5, 2022Sale(10b5-1 plan)−52,552$24.26$1.27M506,630
Robert J. Gould
Director
Apr 4, 2022Option exercise+7,235$7.84$56.72K513,865
Robert J. Gould
Director
Apr 4, 2022Sale(10b5-1 plan)−7,235$24.02$173.78K506,630
Robert J. Gould
Director
Apr 1, 2022Sale(10b5-1 plan)−34,464$24.03$828.17K506,630
Robert J. Gould
Director
Apr 1, 2022Option exercise+34,464$7.84$270.20K541,094
Curtis Gale Oltmans
SVP, General Counsel
Dec 17, 2021Gift−1,088––1,248
Mark J. Levin
Director, 10% owner
Nov 10, 2021Other−1,000,000––3,962,202
Kevin P. Starr
10% owner
Nov 10, 2021Other−1,000,000––3,962,202
Kevin P. Starr
10% owner
Sep 22, 2021Other−1,000,000––4,962,202
Mark J. Levin
Director, 10% owner
Sep 22, 2021Other−1,000,000––4,962,202
Bryan Stuart
See Remarks, Director
Aug 11, 2021Sale(10b5-1 plan)−28,000$23.75$665.00K0
Bryan Stuart
See Remarks, Director
Aug 11, 2021Option exercise+28,000$7.84$219.52K28,000
Christopher Moxham
Chief Scientific Officer
Aug 10, 2021Option exercise+20,714$7.84$162.40K20,714
Christopher Moxham
Chief Scientific Officer
Aug 10, 2021Sale(10b5-1 plan)−20,714$17.00$352.14K0
Christopher Moxham
Chief Scientific Officer
Aug 10, 2021Option exercise+31,071$7.84$243.60K31,071
Christopher Moxham
Chief Scientific Officer
Aug 10, 2021Sale(10b5-1 plan)−31,071$18.00$559.28K0

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
12.92%
6M shares short
Days to cover
4.8
At 1M shares a day
Change since last report
-4.7%
From 7M shares
Short volume, 20 days
49.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Fulcrum Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 17,115 shares on Aug 20, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Greg Tourangeau
former officer
Sep 2, 202614,062$54.42KSep 2, 2026Restricted Stock Awards
Alan Ezekowitz
Director
Jun 26, 202618,000$64.98KJun 26, 2026Restricted Stock Units
Curtis Gale Oltmans
Officer
Dec 15, 20253,452$44.88KDec 15, 2025Employee Stock Purchase Plan
Capital Healthcare Fund LP RA
10% Stockholder
Dec 8, 20254,175,139$54.24MDec 8, 2025Secondary
Robert J. Gould
Director
Nov 19, 202545,000$437.85KNov 19, 2025Founders Shares
Greg Tourangeau
Officer
Mar 8, 20244,884$57.22KMar 8, 2024Stock option exercises

See a number that looks wrong?